What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class I recall involving a specific medical supply product distributed by AVID Medical, Inc. This action centers on the Halyard IV START KIT, specifically identified by the non-sterile designation and reference number KRIV26-02. It is important to understand that this is not a broad recall of all Halyard products or even all IV start kits. Instead, it targets a precise subset of inventory that was manufactured, packaged, and distributed under very specific conditions. The product in question is designed to facilitate the insertion of intravenous lines, but the particular batch involved contains components that were not intended to be used in this manner due to contamination risks.
The core of the issue lies in the contents of these convenience kits. Each recalled kit includes two distinct antiseptic applicators: BD ChloraPrep Clear with a volume of 1 mL and FREPP Clear with a volume of 1.5 mL. These items are typically used to clean the skin prior to needle insertion to reduce the risk of infection. However, in this specific recall, these applicators were found to be contaminated with Aspergillus penicillioides, a type of mold. This contamination occurred within the context of kits that were labeled and distributed as non-sterile. The presence of this fungal organism in a product intended for use on open skin sites or near vascular access points poses a significant safety concern, which is why the FDA has classified this as a Class I recall—the most serious category, indicating a reasonable probability that the use of the product will cause serious adverse health consequences or death.
To help healthcare providers and facilities identify exactly which units are affected, the recall record provides critical tracking details. The specific lot number associated with this contamination is 1658437. Additionally, the Unique Device Identifier (UDI) for the recalled item is 10809160460481. These numbers are your primary tools for verification. If you are a medical professional or facility manager, you must cross-reference these identifiers against your current inventory logs. The distribution pattern for this recall indicates that these kits were sold nationwide within the state of Nebraska. The recall was officially initiated on July 14, 2026. It is vital to note that while the distribution is listed as "US Nationwide" in the broad sense of federal records, the specific geographic scope mentioned is limited to the state of NE. If you are located outside of this region, you may still be affected if your supply chain extended beyond these borders, but the primary affected area identified in the record is Nebraska. There is no mention of other states or international markets in this specific recall notice, so you should rely strictly on the lot and UDI numbers to confirm if your stock is part of this batch.
Understanding the scope of this recall helps clarify why immediate action is necessary. The Halyard IV START KIT REF: KRIV26-02 from lot 1658437 was marketed as a convenience kit, implying it was ready for immediate use in clinical settings. The non-sterile nature of the kit, combined with the biological contamination, creates a unique hazard profile that differs from standard sterility failures. This is not a case of a package being torn or a needle being dull; it is a case of biological integrity being compromised within a product meant for invasive procedures. Therefore, any unit matching these specific identifiers must be treated with extreme caution. The recall does not mention a remedy at this time, meaning there is no official instruction yet on how to return the items or receive replacements. Until further guidance is provided by AVID Medical, Inc. or the FDA, the safest course of action is to isolate any matching inventory and cease its use entirely. Do not attempt to sterilize the kits yourself, as the contamination with Aspergillus penicillioides cannot be reliably removed by standard cleaning methods used in typical medical settings.
The hazard, explained
When medical devices are intended to bypass the body’s natural defenses, sterility is not just a quality standard—it is the primary safety mechanism. In this specific recall involving AVID Medical’s Halyard IV START KIT NON-STERILE (Reference KRIV26-02), the fundamental failure lies in the contamination of components that are supposed to be free from living organisms. The FDA has identified that these convenience kits contain BD ChloraPrep Clear and FREPP Clear Applicators that are contaminated with Aspergillus penicillioides. To understand why this is significant, we must look at what this organism is and how it interacts with the human body when introduced directly into the bloodstream.
Aspergillus penicillioides belongs to a large group of fungi commonly known as molds. While you might encounter these spores in everyday environments—on damp walls, in soil, or on decaying vegetation—they are typically harmless to people with healthy immune systems because our bodies easily manage or expel them. However, the context here is critical. These kits are designed for intravenous (IV) use, meaning the applicators come into direct contact with skin that has been prepped for needle insertion, or they may be used in ways that allow fungal material to enter the sterile field of an IV line. When a mold like Aspergillus enters the body through a break in the skin or directly into the bloodstream, it bypasses the immune system’s first line of defense.
The physical mechanism of harm occurs when these fungal spores germinate and grow within the body’s tissues. Unlike bacteria, which can multiply rapidly on their own, fungi often form hyphae—thread-like structures that can invade tissue. If contaminated applicators are used to prepare a site for an IV catheter, or if the solution itself is compromised, the risk shifts from minor surface irritation to systemic infection. This condition, known as invasive aspergillosis, is particularly dangerous because it can affect vital organs such as the lungs, brain, and heart. The fungi can block blood vessels, leading to tissue death (infarction), or trigger severe inflammatory responses that are difficult for the medical team to treat.
It is important to note that this recall classifies the issue as a Class I hazard, which represents the highest level of regulatory concern. This classification indicates that using or encountering the defective product is likely to cause serious adverse health consequences or death. The danger is not merely theoretical; it is rooted in the biological reality that introducing non-sterile fungal material into a sterile medical procedure creates an open door for infection. For patients whose immune systems are already weakened due to illness, age, or medication, this risk is exponentially higher. The contamination essentially turns a routine preparatory step into a potential vector for a life-threatening systemic fungal infection, which requires aggressive and often toxic antifungal treatments to resolve.
Furthermore, the nature of Aspergillus means that symptoms may not appear immediately. Patients might experience subtle signs such as persistent fever, chills, or localized pain at the IV site days after the procedure. Because these symptoms mimic common post-procedure discomforts or other infections, the specific link to fungal contamination can be missed without proper testing. This delay in diagnosis allows the infection to progress deeper into the body before treatment begins, complicating recovery and increasing the likelihood of long-term complications. Therefore, understanding this hazard is not just about knowing a product is defective; it is about recognizing the silent, biological threat posed by introducing environmental fungi directly into the sterile internal environment of the human body.
Who is most at risk
The primary group affected by this recall consists of healthcare professionals and clinical staff who utilize the Halyard IV START KIT in patient care settings. Because the product was distributed nationwide with specific mentions of distribution patterns in Nebraska, any medical facility, clinic, or home health agency that received inventory under lot number 1658437 is potentially holding the compromised kits. The risk here is not limited to the individual who unpacks the box; it extends to every patient who might receive an intravenous line inserted using these contaminated applicators. In a clinical environment, this includes patients undergoing surgery, those receiving chemotherapy, individuals with chronic conditions requiring regular IV access, and emergency room patients needing immediate fluid or medication delivery.
The biological hazard at the center of this issue—Aspergillus penicillioides—introduces a specific and serious vulnerability for immunocompromised individuals. This mold is an opportunistic pathogen, meaning it typically does not cause illness in healthy people with robust immune systems. However, for patients whose bodies are already fighting other illnesses or who have conditions that weaken their defenses, the stakes are significantly higher. Elderly patients, infants, and those undergoing treatments that suppress the immune system, such as cancer therapy or organ transplant recipients, are particularly susceptible to invasive fungal infections. If these spores enter the bloodstream through the IV site, they can lead to severe systemic infections that are difficult to treat and potentially life-threatening.
Furthermore, the non-sterile nature of this specific kit amplifies the risk for anyone with broken skin or compromised vascular access sites. Patients with diabetes, those suffering from peripheral vascular disease, or individuals with central venous catheters are at a heightened disadvantage. Their skin barriers may be less effective, or their existing medical devices provide a direct pathway for contaminants to bypass normal immune defenses. The concern is that the contamination was present within convenience kits designed for ease of use, which might lead staff to assume they are sterile and safe without immediate visual inspection. This creates a silent risk where the product looks functional but harbors biological hazards invisible to the naked eye.
While the recall classification is Class I, indicating the highest degree of danger, it is important to note that no specific incidents or injuries have been reported in the available records as of the recall date. This does not mean the risk is absent; rather, it means the harm has not yet materialized publicly. The vulnerability lies in the potential for future exposure. Any patient who receives care from a provider using lot 1658437 of this specific AVID Medical kit should be considered potentially exposed. Healthcare providers must act as the first line of defense, ensuring that no patient receives treatment with these compromised tools, thereby protecting the most fragile members of our community from preventable fungal complications.
How to tell if you have the recalled item
Identifying the specific medical device involved in this recall requires careful attention to a few distinct physical labels and documentation details. Because this is a Class I recall involving sterile or non-sterile convenience kits, manufacturers use standardized tracking systems like Lot Numbers and Unique Device Identifiers (UDI) to ensure traceability. If you are a healthcare provider, pharmacy technician, or even a patient who received this kit directly, you need to verify the exact reference number, lot code, and UDI before taking any action. Do not rely on general descriptions alone; these kits can look very similar to other products from different manufacturers or even different product lines within the same brand.
First, locate the primary product label on the packaging of the Halyard IV START KIT. You are looking for a non-sterile convenience kit produced by AVID Medical. The most critical piece of information here is the Reference Number. You must confirm that the kit bears the specific reference code KRIV26-02. This code distinguishes this particular configuration from other Halyard kits that may contain similar items but were not part of this specific contamination event. If the reference number differs, even slightly, this recall does not apply to your item.
Next, examine the lot identification. The recall is limited to a single batch of products. You must find the Lot Number printed on the packaging and verify that it matches 1658437. Lot numbers are typically printed in bold or black ink on the side or back of the box. If your kit has a different lot number, it was manufactured at a different time and is not subject to this specific recall notice. It is also helpful to check the Unique Device Identifier (UDI), which is listed as 10809160460481. While the UDI is complex, having this number allows you to cross-reference your inventory with FDA databases or contact the manufacturer for definitive confirmation.
Once you have verified the Reference Number, Lot Number, and UDI, check the physical contents of the kit. This specific non-sterile kit is described as containing BD ChloraPrep Clear applicators in a 1 mL size, along with FREPP Clear Applicators in a 1.5 mL size. The presence of these specific contaminated items—BD ChloraPrep Clear and FREPP Clear—is the core reason for the recall due to potential biological contamination with Aspergillus penicillioides. However, remember that distribution was limited. According to the record, this product was distributed nationwide but specifically noted in the state of Nebraska (NE). If you are outside of Virginia (VA) or did not receive it through channels associated with Nebraska distribution, the likelihood of having this exact recalled unit is lower, but verification remains essential. Do not discard the packaging until you have confirmed these details, as it contains the necessary evidence for any potential remedy or return process.
What to do — step by step
If you are in possession of the recalled AVID Medical Halyard IV START KIT NON-STERILE (Reference Number KRIV26-02), your immediate priority is to ensure that this specific product is never used on a patient. Because the recall involves a Class I hazard related to biological contamination, taking swift and decisive action is essential for maintaining safety standards in any clinical or home-care setting. The first and most critical step you must take is to immediately stop using the kit. Do not attempt to sterilize it yourself, do not open the packaging to inspect the contents further than necessary for identification, and do not use the BD ChloraPrep Clear or FREPP Clear Applicators contained within. Once a device in this category is identified as potentially contaminated with Aspergillus penicillioides, it cannot be safely repurposed or cleaned by standard means.
The next phase of your response involves identifying exactly which units are affected so they can be properly segregated from your active inventory. You need to locate the specific lot number and UDI (Unique Device Identifier) on the packaging. For this recall, you are looking for Lot Number 1658437 and UDI 10809160460481. If your records or physical stock match these identifiers, those kits must be removed from circulation immediately. Quarantine these items in a secure area to prevent accidental use by staff or other caregivers who might not be aware of the recall status.
It is important to address the remedy directly: the FDA recall facts for this specific batch do not currently state a specific remedy, such as a mandatory return process, a prepaid shipping label, or a direct refund mechanism. This does not mean you should ignore the issue, but rather that the standard protocol may differ from recalls where the manufacturer provides a simple exchange program. In cases where the remedy is not explicitly detailed in the public notice, your primary obligation shifts to containment and reporting. You should contact AVID Medical directly or reach out to the FDA’s MedWatch program to report your possession of the product. This helps regulatory agencies track the extent of the distribution and ensures that any future instructions are communicated effectively to all stakeholders.
If you are a healthcare provider, you must also notify your infection control team and document the incident in your facility’s adverse event reporting system. Even without a stated refund or replacement plan, keeping a detailed record of the lot numbers and the date of discovery is vital for liability and safety audits. Do not dispose of the contaminated kits in regular trash if possible; follow your institution’s biohazard waste disposal protocols until further guidance is provided by the manufacturer or regulatory bodies. Your vigilance in isolating these items protects patients from potential fungal exposure and supports the broader effort to maintain sterile integrity in medical supplies.
Your refund, repair, or replacement options
When a medical device is recalled due to safety concerns, the most immediate question for patients and healthcare providers is often, "What happens next?" In this specific case involving AVID Medical, Inc., the recall of the Halyard IV START KIT NON-STERILE (Reference Number: KRIV26-02) presents a unique situation because the official FDA record does not explicitly state the remedy. This means there is no published instruction for a refund, repair, or replacement at this time. While it may be surprising to find that the government report omits these details, it is important to understand why and what you can do instead.
The absence of a stated remedy in the recall notice does not mean that help is unavailable. It simply means that the standard process for getting your money back or receiving a safe replacement has not been publicly standardized in this specific document. In many medical device recalls, the company will issue a separate communication to healthcare facilities and distributors with detailed instructions on how to return the product or receive credit. Since this recall involves Class I items distributed in Nebraska, the responsibility for managing these logistics likely falls directly on AVID Medical’s internal customer service team rather than a public-facing government portal.
If you are a healthcare provider who has used or currently holds this kit, you should contact AVID Medical, Inc., directly. Do not wait for a letter in the mail, as medical supplies often move quickly through hospital inventories. When you reach out to them, have your lot number (1658437) and UDI (10809160460481) ready. These identifiers are critical because they allow their customer service team to verify exactly which batch of products you have. By providing these specific details, you help them track the contaminated items accurately. They may offer you a replacement kit that is verified as sterile and free from Aspergillus penicillioides contamination, or they might arrange for a credit to your account once the unsafe kits are returned.
If you are a patient who has already received care using this product, your path forward is different. You do not need to contact AVID Medical directly to get a refund, as you likely did not purchase the kit yourself; it was provided by a hospital or clinic. Instead, your primary concern should be your health. If you have had an IV inserted with this specific non-sterile kit, discuss any signs of infection with your doctor. The recall is primarily about preventing future exposure to contamination, not necessarily about reversing past events. However, if you are concerned about the safety of your care, ask your healthcare provider to review their inventory and ensure they have removed all kits from Lot 1658437 from use immediately.
In summary, while the official recall notice does not list a refund or replacement program, options do exist through direct contact with the manufacturer. AVID Medical is responsible for managing the logistics of this Class I recall. For consumers and providers alike, the best course of action is to stop using the product immediately and reach out to the company’s support team with your specific lot information. They are the only ones who can confirm whether a credit, repair, or replacement is available for your specific situation.
What can happen if you ignore it
When a medical device is recalled due to contamination, the decision to continue using the item might seem harmless in the moment, especially if the packaging appears intact or the product looks normal. However, with the AVID Medical Halyard IV START KIT NON-STERILE (Ref: KRIV26-02), ignoring this recall carries significant and potentially serious health risks that go far beyond a simple inconvenience. The core issue here is not mechanical failure or incorrect labeling, but biological contamination. Specifically, certain lots of these convenience kits contain BD ChloraPrep Clear and FREPP Clear Applicators that have been found to be contaminated with Aspergillus penicillioides. Understanding what this means for your health requires looking at how fungal spores interact with the human body, particularly in vulnerable clinical settings.
Aspergillus penicillioides is a type of mold. While mold is something we encounter daily in our environment—on bread, in soil, or in damp corners of a house—our immune systems are generally well-equipped to handle minor exposures. The danger arises when these fungal spores are introduced directly into the body through a break in the skin or mucous membranes. In the context of an IV start kit, the applicators are designed to clean the site where a needle will penetrate the skin. If that cleaning tool itself is carrying live fungal spores, you are essentially planting those spores directly into the tissue just before a catheter is inserted. This bypasses the body’s primary defense layer: the skin.
For individuals with robust immune systems, the risk of a serious infection from this specific exposure may be lower than for others, but it is not zero. The introduction of foreign biological material into a sterile field can trigger an inflammatory response or lead to localized infections. However, the situation becomes critically dangerous for immunocompromised patients. Those undergoing chemotherapy, organ transplant recipients, individuals with HIV/AIDS, or patients on high-dose corticosteroids have weakened defenses. For these populations, even a small number of fungal spores can lead to invasive aspergillosis, a severe and potentially life-threatening infection that can spread to the lungs, blood, and other organs. Fungal infections are notoriously difficult to treat compared to bacterial ones, often requiring long courses of specialized antifungal medications that carry their own side effects.
There is also the risk of complicating existing medical treatments. If an IV line is established using contaminated supplies, the resulting infection can delay necessary surgeries, interrupt chemotherapy regimens, or prolong hospital stays. The financial and emotional toll of treating a preventable healthcare-associated infection is substantial. While the recall notice does not currently list specific reported injuries or deaths associated with this lot, the potential for harm is inherent in the nature of the hazard. Medical devices are intended to reduce risk, not introduce new biological threats. Continuing to use these kits disregards the safety protocols designed to protect patients from exactly this type of contamination event.
It is important to note that you cannot identify contaminated items by looking at them. The BD ChloraPrep Clear and FREPP Clear Applicators inside the Halyard IV START KIT will appear normal, sterile, and ready for use. There are no visible signs of mold or spoilage on the surface of the applicators or within the sealed packaging that would alert a user to the presence of Aspergillus penicillioides. Therefore, ignoring the recall relies on the false assumption that "if it looks fine, it is safe." In this case, visual inspection is useless. The only way to avoid the risk of fungal introduction and subsequent infection is to ensure that these specific kits are never used on any patient, regardless of how healthy or robust that patient appears to be.
Staying safe: broader tips
While this specific recall highlights a contamination issue with a particular medical device kit, the underlying principle of safety applies to all healthcare products you use at home or in clinical settings. The most critical step in preventing adverse events is proactive vigilance. This means regularly checking the U.S. Food and Drug Administration (FDA) website for new recalls. You do not need to wait for a news alert; set aside time each month to review recent updates, particularly for items you use frequently or that are close to their expiration dates. Subscribing to FDA email alerts for medical devices can help ensure you receive timely notifications directly, allowing you to act before a potential hazard affects your health.
When handling any medical supply, even those that appear standard, always verify the sterility and integrity of the packaging before use. In the context of intravenous (IV) kits and similar sterile devices, the barrier between the product and the environment is your first line of defense. If a wrapper is torn, punctured, or feels damp, do not assume it is safe to proceed. Contaminants like mold spores, such as Aspergillus, can be invisible to the naked eye but pose serious risks if they enter the bloodstream. Always inspect the expiration date printed on the box and the individual pouches. Time degrades materials and can compromise sterility, so never use a product that is past its recommended shelf life, regardless of how it looks.
Proper storage is equally important in maintaining product safety. Medical kits should be kept in a clean, dry, and temperature-controlled environment. Avoid storing them in bathrooms or areas with high humidity, as moisture can penetrate packaging over time and create an environment conducive to microbial growth. If you are a healthcare provider, ensure that your inventory management system tracks lot numbers effectively so that any future recalls can be addressed quickly. For individual consumers, keep a record of the lot numbers for critical medical supplies in a safe place, separate from the products themselves, but easily accessible if needed.
Finally, never hesitate to contact a healthcare professional or the manufacturer if you have questions about a product’s safety or suitability for your needs. If you suspect you have used a recalled item or notice any unusual symptoms after using a medical device, seek medical attention immediately and report the incident to the FDA’s MedWatch program. Your awareness and willingness to ask questions are powerful tools in protecting your health. By staying informed and handling products with care, you turn passive consumption into active safety management.